Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Change in Cash (2022 - 2025)

Historic Change in Cash for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to -$1.6 million.

  • Coya Therapeutics' Change in Cash rose 7050.47% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year decrease of 11451.35%. This contributed to the annual value of $5.7 million for FY2024, which is 7859.75% down from last year.
  • Per Coya Therapeutics' latest filing, its Change in Cash stood at -$1.6 million for Q3 2025, which was up 7050.47% from -$5.8 million recorded in Q2 2025.
  • Coya Therapeutics' 5-year Change in Cash high stood at $21.7 million for Q4 2023, and its period low was -$5.8 million during Q2 2025.
  • Over the past 4 years, Coya Therapeutics' median Change in Cash value was -$1.7 million (recorded in 2022), while the average stood at $1.6 million.
  • Per our database at Business Quant, Coya Therapeutics' Change in Cash soared by 90012.21% in 2023 and then plummeted by 108573.73% in 2025.
  • Coya Therapeutics' Change in Cash (Quarter) stood at -$2.7 million in 2022, then soared by 900.12% to $21.7 million in 2023, then crashed by 66.5% to $7.3 million in 2024, then tumbled by 122.35% to -$1.6 million in 2025.
  • Its Change in Cash was -$1.6 million in Q3 2025, compared to -$5.8 million in Q2 2025 and -$2.8 million in Q1 2025.